Novartis.com | Contact Us | Help | Site Map | Stay Connected | Large Text Version Regular Text Version

Home
Site Map

Site Map

Home

Research Innovation

About Us
- Our Vision
- Our Global Sites
  - Albania
  - Argentina
  - Australia
  - Austria
  - Belgium
  - Brazil
  - Bulgaria
  - Canada
  - China
  - Colombia
  - Croatia
  - Denmark
  - Ecuador
  - Estonia
  - Finland
  - France
  - Germany
  - Greece
  - Italy
  - Japan
  - Latvia
  - Lithuania
  - Mexico
  - Netherlands
  - Norway
  - Perú
  - Poland
  - Romania
  - Russia
  - Serbia
  - Slovenia
  - South Korea
  - Spain
  - Sweden
  - Switzerland
  - Thailand
  - Turkey
  - United States
  - Venezuela
Media
- Products
  - Afinitor
  - Exjade
  - Femara
  - Glivec
  - Sandostatin LAR
  - Tasigna
  - Zometa
- Research
- Press Releases
Careers

SEARCH OUR WEBSITES

ABOUT NOVARTIS ONCOLOGY

Learn More About Novartis Oncology

We deliver a broad range of innovative therapies, cancer resources and oncology drugs to improve and extend the lives of cancer patients.

Learn more about Novartis Oncology

RESEARCH INNOVATION

Novartis maintains the most promising oncology drug pipeline in the industry to treat and help people around the world.

Use of this website is governed by our Terms of Use and Privacy Policy. © Novartis AG

Disclaimer: This site is intended to provide information to audiences outside the United States. Please note that not all products listed within this site may be available in all countries. Also, prescribing information and indications for products may differ from country to country, so please consult your local Novartis company for local prescribing and any other information you may be interested in.